G1 Therapeutics
A company developing small molecule therapies to treat cancer
All edits
Tavistock Life Sciences
Halozyme Therapeutics
Engineering
Consumer biotechnology
Durham, North Carolina
Research Triangle Park
DelawareMarch 29, 2019
On February 5, 2015 G1 Therapeutics completed their series B funding round with $33 million in funding from Ra Capital Management (lead investor), Eshelman Ventures (lead investor), Mountain Group Capital, MedImmune Ventures, Lumira Ventures, and Hatteras Venture Partners.
March 29, 2019
On May 11, 2016 G1 Therapeutics completed their series C funding round with $47 million in funding from Cormorant Asset Management (lead investor), Tavistock Life Sciences, Rock Springs Capital, RA Capital Management, Mountain Group Capital, MedImmune Ventures, Lumira Ventures, Hatteras Venture Partners, Franklin Templeton Investments, Eshelman Ventures, and Cowen Group.
October 16, 2013
On October 16, 2013 G1 Therapeutics completed their series A funding round with $12.5 million in funding from MedImmune Ventures (lead investor), Mountain Group Capital, and Hatteras Venture Partners.
October 12, 2012
On October 12, 2012 G1 Therapeutics completed a venture funding round with $762,900 in funding from undisclosed investors.
On October 12, 2012 G1 Therapeutics completed a venture funding round with $762,900 in funding from undisclosed investors.
On October 16, 2013 G1 Therapeutics completed their series A funding round with $12.5 million in funding from MedImmune Ventures (lead investor), Mountain Group Capital, and Hatteras Venture Partners.
On February 5, 2015 G1 Therapeutics completed their series B funding round with $33 million in funding from Ra Capital Management (lead investor), Eshelman Ventures (lead investor), Mountain Group Capital, MedImmune Ventures, Lumira Ventures, and Hatteras Venture Partners.
On May 11, 2016 G1 Therapeutics completed their series C funding round with $47 million in funding from Cormorant Asset Management (lead investor), Tavistock Life Sciences, Rock Springs Capital, RA Capital Management, Mountain Group Capital, MedImmune Ventures, Lumira Ventures, Hatteras Venture Partners, Franklin Templeton Investments, Eshelman Ventures, and Cowen Group.
Lumira Ventures
Kwok-Kin Wong
Norman Sharpless
Jack Bailey
Alicia Secor
United States
North Carolina
Nasdaq
Organization